Refolding and Characterization of Recombinant Human Soluble CTLA-4 Expressed in Escherichia coli

By Cox G.N.   Pratt D.   Smith D.   Mcdermott M.J.   vanderslice R.W.  

Protein Expression and Purification, Vol. 17, Iss. 1, 1999-10 ,pp. : 26-32

Academic Press

Access to resources Recommend Favorite

Potent Inhibition of CTLA-4 Expression by an Anti-CTLA-4 Ribozyme

By Cepero E.   Hnatyszyn H.J.   Kraus G.   Lichtenheld M.G.  

Biochemical and Biophysical Research Communications, Vol. 247, Iss. 3, 1998-06 ,pp. : 838-843

Elsevier

Access to resources Recommend Favorite

Update on anti-CTLA-4 antibodies in clinical trials

By Langer Lee F   Clay Timothy M   Morse Michael A  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 8, 2007-08 ,pp. : 1245-1256

Informa Healthcare

Access to resources Recommend Favorite

Molecular Weights of CTLA-4 and CD80 by Sedimentation Equilibrium Ultracentrifugation

By Fairman R.   Fenderson W.   Hail M.E.   Wu Y.   Shaw S-Y.  

Analytical Biochemistry, Vol. 270, Iss. 2, 1999-06 ,pp. : 286-295

Elsevier

Access to resources Recommend Favorite

Src Family Tyrosine Kinases Associate with and Phosphorylate CTLA-4 (CD152)

By Miyatake S.   Nakaseko C.   Umemori H.   Yamamoto T.   Saito T.  

Biochemical and Biophysical Research Communications, Vol. 249, Iss. 2, 1998-08 ,pp. : 444-448

Elsevier

Access to resources Recommend Favorite